Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells

被引:89
作者
Ikegawa, T
Ushigome, F
Koyabu, N
Morimoto, S
Shoyama, Y
Naito, M
Tsuruo, T
Ohtani, H
Sawada, Y
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Higashi Ku, Fukuoka 8128582, Japan
[2] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
关键词
grapefruit juice; orange juice; methoxyflavone; vincristine; multidrug resistance; cancer chemotherapy;
D O I
10.1016/S0304-3835(00)00549-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated the effects of the ethyl acetate extract of grapefruit juice (GFJ), that of orange juice (OJ) and their components on the uptake of [H-3]vincristine into adriamycin-resistant human myelogenous leukemia cells. Its uptake was increased by the extracts of GFJ and OJ up to 7- and 3-fold, respectively, as well as verapamil and cyclosporin A. OJ components, i.e. 3,3',4'.5.6,7,8-heptamethoxyflavone, nobiletin and tangeretin, also increased the uptake of [H-3]vincristine in a concentration-dependent manner. Although GFJ components, dihydroxybergamottin and bergamottin, significantly increased the uptake, their potencies were considerably weaker than those of OJ components. These data suggest that OJ components inhibit P-gp-mediated efflux of [H-3]vincristine, resulting in the intracellular accumulation of chamotherapeutic drugs. These components may become candidates of multi-drug resistance reversing agents in cancer chemotherapy. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [41] Design and evaluation of dibenzoazepine-tetrahydroisoquinoline hybrids as potential P-glycoprotein inhibitors against multidrug resistant K562/A02 cells
    Jiang, Chunyu
    Pan, Ting
    Jiang, Yunxiang
    Zhang, Zhiyu
    Zeng, Meifeng
    Sun, Shuang
    Li, Zheng
    Wu, Yiqing
    Qiu, Jingying
    Niu, Mingshan
    Gu, Xiaoke
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 249
  • [42] Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells
    Yousefi, B.
    Samadi, N.
    Baradaran, B.
    Rameshknia, V.
    Shafiei-Irannejad, V.
    Majidinia, M.
    Targhaze, N.
    Zarghami, N.
    CELLULAR AND MOLECULAR BIOLOGY, 2015, 61 (08) : 118 - 122
  • [43] Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin
    Yalcintepe, Leman
    Halis, Emre
    Ulku, Sibel
    ONCOLOGY LETTERS, 2016, 11 (03) : 2290 - 2296
  • [44] Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in Caco-2 cells
    Takanaga, H
    Ohnishi, A
    Matsuo, H
    Sawada, Y
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1998, 21 (10) : 1062 - 1066
  • [45] Combination of dihydromyricetin and ondansetron strengthens antiproliferative efficiency of adriamycin in K562/ADR through downregulation of SORCIN: A new strategy of inhibiting P-glycoprotein
    Sun, Yaoting
    Liu, Wei
    Wang, Changyuan
    Meng, Qiang
    Liu, Zhihao
    Huo, Xiaokui
    Yang, Xiaobo
    Sun, Pengyuan
    Sun, Huijun
    Ma, Xiaodong
    Peng, Jinyong
    Liu, Kexin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) : 3685 - 3696
  • [46] B3, a novel modulator of P-glycoprotein mediated multidrug resistance in K562/A02 cells
    Fang, Weirong
    Li, Yunman
    Cai, Ying
    Kang, Kai
    Liu, Guoqing
    Huang, Wenlong
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 71 - 71
  • [47] Anti-proliferative effect of the abl tyrosine kinase inhibitor STI571 on the P-glycoprotein positive K562/ADM cell line
    Kotaki, M
    Motoji, T
    Takanashi, M
    Wang, YH
    Mizoguchi, H
    CANCER LETTERS, 2003, 199 (01) : 61 - 68
  • [48] Chemical constituents from Cicuta virosa Linnaeus and their reversal effects on doxorubicin-resistant human myelogenous leukemia (K562/A02) cells
    Wang, Shu-Qi
    Zhang, Qing-Wei
    Wang, Xiao-Ling
    Di, Xia-Xia
    Wang, Xiao-Ning
    Lou, Hong-Xiang
    CHINESE CHEMICAL LETTERS, 2016, 27 (07) : 1013 - 1016
  • [49] The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line
    Zhang, Yang-Yang
    Xie, Ke-Ming
    Yang, Guo-Qing
    Mu, Hui-Jun
    Yin, Ying
    Zhang, Bin
    Xie, Ping
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (03) : 361 - 367
  • [50] Designed P-glycoprotein inhibitors with triazol-tetrahydroisoquinoline-core increase doxorubicin-induced mortality in multidrug resistant K562/A02 cells
    Kairuki, Mutta
    Qiu, Qianqian
    Pan, Miaobo
    Li, Qifei
    Zhou, Jiaqi
    Ghaleb, Hesham
    Huang, Wenlong
    Qian, Hai
    Jiang, Cheng
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (15) : 3347 - 3357